サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：創傷被覆材の世界市場-2023年～2030年
市場調査レポート
商品コード
1373377

創傷被覆材の世界市場-2023年～2030年

Global Wound Dressing Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 183 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
創傷被覆材の世界市場-2023年～2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 183 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

創傷被覆材は創傷を清潔にし、覆い、外的環境から保護します。湿潤環境を提供し、過剰な滲出液を除去し、浸軟を避け、感染から創傷を保護し、適切なガス交換を維持しなければならないです。

創傷被覆材は滲出液のコントロール、創傷保護、疼痛緩和のために選択されます。ドレッシング材または湿布は、創傷の治癒を促進し、さらなる損傷から創傷を保護するために創傷に適用される滅菌パッドです。最近のドレッシング材には、乾燥または含浸ガーゼ、プラスチックフィルム、ゲル、フォーム、ハイドロコロイド、アルギン酸塩、ハイドロゲル、多糖類のペースト、顆粒、ビーズなどがあります。

市場力学：市場促進要因と市場抑制要因

創傷被覆材に関する調査・投資活動の活発化

先進的な創傷被覆材と創傷ケアを提供するための企業による投資の増加が市場成長を促進すると予想されます。また、新製品の発売や認可の増加も市場成長の原動力になると予想されます。

例えば、2023年5月24日、創傷管理企業のRedDress社は、創傷治癒プロセスをジャンプスタートさせるために人間の血液を利用する技術の開発を継続するため、シリーズD資金調達ラウンドで2,600万米ドルを調達しました。ATHOS Biopharma GmbHを含む投資家が参加したこのラウンドにより、同社の資金調達総額は4,300万米ドルに達しました。

さらに、2021年5月14日、ヒアロジックスは新たに2億4,000万米ドルの株式投資を発表し、患者中心の創傷治療センターを運営するリーディングカンパニーとして成長を続けています。

阻害要因

創傷被覆材に関連する高コスト

高度な創傷被覆材に関連する高コストが市場成長の妨げになると予想されます。褥瘡治療の直接費用は2,000ドルから20,000ドルの間です。

このレポートの詳細について- サンプル請求

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 創傷被覆材に関する調査・投資活動の活発化
      • YY年
    • 抑制要因
      • 創傷被覆材に関連する高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

  • 従来の創傷被覆材
    • ガーゼドレッシング
    • リント
    • プラスター
    • 包帯
    • コットンウール
  • モダン創傷被覆材
    • パッシブ製品
    • インタラクティブ製品
    • 生物活性製品
    • 生物活性創傷被覆材
    • 組織工学的皮膚代替物
    • 薬用ドレッシング
    • 複合ドレッシング材

第8章 素材タイプ別

  • ハイドロコロイド
  • ハイドロゲル
  • コラーゲン
  • アルギン酸塩
  • フォーム
  • 透明
  • 布

第9章 創傷タイプ別

  • 慢性創傷
    • 糖尿病性足潰瘍
    • 褥瘡性潰瘍
    • 静脈性潰瘍
    • その他
  • 急性創傷
    • 手術創
    • 外傷
    • 熱傷

第10章 エンドユーザー別

  • 病院
  • 専門クリニック
  • 調査機関
  • 外傷センター
  • 地域ヘルスケアセンター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Abbott Laboratories
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • BioMerieux SA
  • EKF Diagnostics Holdings plc
  • Atlas Medical
  • Quidel Corporation
  • BIOSYNEX SA
  • NG BIOTECH SAS
  • Axis Medicare
  • Cardinal Health Inc.
  • Thermo Fisher Scientific Inc.

第14章 付録

目次
Product Code: PH1870

Overview

Wound dressings clean, cover, and protect the wound from the external environment. It must provide a moist environment, remove excess exudate, avoid maceration, protect the damage from infection, and maintain an adequate exchange of gases.

Wound dressings are chosen to address exudate control, wound protection, and pain relief. A dressing or compress is a sterile pad applied to a wound to promote healing and protect the wound from further harm. Modern dressings include dry or impregnated gauze, plastic films, gels, foams, hydrocolloids, alginates, hydrogels, and polysaccharide pastes, granules, and beads.

Market Dynamics: Drivers & Restraints

Rising research & investment activities related to wound dressing

The increase in the investments by the companies in order to provide advanced wound dressing and wound care is expected to drive market growth. The increase in the product launches and approvals of the new products is also expected to drive the market growth.

For instance, on May 24, 2023, Wound management company RedDress raised $26m in a Series D financing round to continue developing its technology that harnesses human blood to jump-start the wound healing process. The round, which received participation from investors including ATHOS Biopharma GmbH, brings the company's total funding to $43m.

Additionally, on May 14, 2021, Healogics released a new $240 million equity investment, positioning the Company to continue its growth as a leading patient-centric wound care center operator.

Restraint

High costs associated with the wound dressings

The high cost associated with advanced wound dressing is expected to hamper the market growth. The direct costs for pressure ulcer treatment range between $2,000 and $20,000.

For more details on this report - Request for Sample

Segment Analysis

The global wound dressing market is segmented based on product type, material type, wound type, end-user and region.

Chronic wounds segment accounted for 45.3% of the market share

Chronic wounds segment is expected to hold a significant position in the market position. The increase in chronic wound burdens such as diabetic ulcers, nonhealing surgical wounds, burns, and venous-related ulcerations is expected to increase the demand for wound dressing and thus increase segment growth.

For instance, according to the report issued by Mission Regional Medical Center in 2022, more than 29 million people (9.5% of the population) have diabetes in the United States (US) and almost two million of those people annually will develop a diabetic foot ulcer or other non-healing wound.

Additionally, according to the report by the National Institute of Health in 2023, over 6.7 million people in the United States alone suffer from chronic nonhealing wounds including diabetic ulcers, nonhealing surgical wounds, burns, and venous-related ulcerations.

Geographical Analysis

North America is expected to hold a significant position in the global wound dressing market share

North American region accounted for the largest market share. The increase in the number of product launches, the presence of the major players in the region, and improved healthcare infrastructure in the region are expected to hold the region in the dominant market share.

For instance, on December 8, 2022, NEXGEL Inc. launched a unique hydrogel dressing, called Turfguard, for treating painful turf burns and protecting sports-related wounds.

Additionally, on August 11, 2022, DrySee launched a patented waterproof bandage with a liquid intrusion alert to users and caregivers when water or other liquids have penetrated the bandage. Thus, introducing new products and approvals is expected to drive the market growth in the region.

COVID-19 Impact Analysis:

COVID-19 pandemic was expected to lower the use of advanced wound dressing, as they require healthcare advice, thereby restricting the market's growth. The disruption in the supply chains and closure of the hospitals have affected the market growth negatively.

Competitive Landscape

The leading companies with a significant market share include: 3M Company, Dukal Corporation, Integra Lifesciences Holdings Corporation, Medline Industries Inc., Mckesson Corporation, Acelity L.P. Inc., Molnlycke Health Care, Coloplast Corp., Argentum Medical LLC, Urgo Medical among others.

Key Developments

  • On 3 January 2023, Convatec launched ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients.
  • On October 18, 2023, DuPont launched a new soft skin adhesive for wound care dressings. The non-sensitizing, non-irritating, and non-cytotoxic adhesive helps to protect the highly sensitive and fragile skin.

Why Purchase the Report?

  • To visualize the global wound dressing market segmentation based on product type, material type, wound type, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of wound dressing market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global wound dressing market report would provide approximately 69 tables, 71 figures, and 183 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by Wound Type
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising research & investment activities related to wound dressing
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. High costs associated with the wound dressings
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Traditional Wound Dressing *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Gauze Dressing
    • 7.2.4. Lint
    • 7.2.5. Plasters
    • 7.2.6. Bandages
    • 7.2.7. Cotton Wool
  • 7.3. Modern Wound Dressing
    • 7.3.1. Passive Products
    • 7.3.2. Interactive Products
    • 7.3.3. Bioactive Products
    • 7.3.4. Bioactive Wound Dressing
    • 7.3.5. Tissue-Engineered Skin Substitutes
    • 7.3.6. Medicated Dressing
    • 7.3.7. Composite Dressing

8. By Material Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 8.1.2. Market Attractiveness Index, By Material Type
  • 8.2. Hydrocolloid *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hydrogel
  • 8.4. Collagen
  • 8.5. Alginate
  • 8.6. Foam
  • 8.7. Transparent
  • 8.8. Cloth

9. By Wound Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 9.1.2. Market Attractiveness Index, By Wound Type
  • 9.2. Chronic Wounds *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 9.2.3. Diabetic foot Ulcers
    • 9.2.4. Pressure Ulcers
    • 9.2.5. Venous Ulcers
    • 9.2.6. Others
  • 9.3. Acute Wounds
    • 9.3.1. Surgical wounds
    • 9.3.2. Traumatic wounds
    • 9.3.3. Burns

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty Clinics
  • 10.4. Research Organizations
  • 10.5. Trauma Centers
  • 10.6. Community Healthcare Centers
  • 10.7. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Abbott Laboratories *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. BioMerieux SA
  • 13.3. EKF Diagnostics Holdings plc
  • 13.4. Atlas Medical
  • 13.5. Quidel Corporation
  • 13.6. BIOSYNEX SA
  • 13.7. NG BIOTECH SAS
  • 13.8. Axis Medicare
  • 13.9. Cardinal Health Inc.
  • 13.10. Thermo Fisher Scientific Inc.

LIST NOT EXHAUSTIVE.

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us